GalaGen President Interviewed
on CEOCast.com
President and CEO Henry Cardello discusses the diverse applications for GalaGen's immune-enhancing technology and reports on the status of GalaGen's alliances with major consumer products companies.
For details and this audio presentation, click
here.
|
|
Annual Meeting Presentations
Slides from presentations by GalaGen Chairman & CTO Robert Hoerr, M.D., CFO Franklin Kuhar and President and CEO Henry Cardello. Click here. |
|
GalaGen Inc. provides innovative nutritional ingredients for the food, beverage and supplement industries to enhance immunity and promote wellness. Its patented, proprietary processes and ingredients (including Proventra™ Natural Immune Components) are the result of more than a decade of research and development.
"The desire to live a healthier, more productive and longer life is not a passing trend," says Robert Hoerr, M.D., Ph.D., chairman and chief technology officer of GalaGen. "Yet our emphasis as a company is not on discovering a fountain of youth or cure-all for today's consumer. Our focus is on offering safe, research-based ingredients which boost our bodies' natural resistance."
GalaGen's dedication to reliability, safety and science-based research has attracted the attention of many of the nation's most progressive food and beverage companies. These manufacturers are turning to GalaGen in response to consumer interest in the issue of immunity.
- To date, GalaGen has forged collaborative partnerships with:
- Tropicana, a subsidiary of PepsiCo
- Novartis Consumer Health
- General Nutrition Corporation
- Hormel HealthLabs, a subsidiary of Hormel Foods Corporation
- Wyeth-Ayerst, a subsidiary of American Home Products
Corporation
- Lifeway Foods, a food company partly owned by Danone Groupe
These partnerships will result in new products with immune-boosting benefits (containing Proventra™), as well as additional products with other health benefits.
GalaGen is developing other health-enhancing ingredients in addition to Proventra. Over the past decade we have developed proprietary technologies capable of addressing a wide variety of health conditions.
|
